Nippon Chemiphar Co., Ltd. (4539.T)
JPY 1455.0
(0.21%)
JPY 1455.0
(0.21%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 30.74 Billion JPY | -2.57% |
| 2022 | 31.55 Billion JPY | -2.91% |
| 2021 | 32.5 Billion JPY | 3.06% |
| 2020 | 31.54 Billion JPY | -0.68% |
| 2019 | 31.75 Billion JPY | -7.09% |
| 2018 | 34.18 Billion JPY | -3.25% |
| 2017 | 35.33 Billion JPY | -1.0% |
| 2016 | 35.68 Billion JPY | 0.24% |
| 2015 | 35.6 Billion JPY | 1.38% |
| 2014 | 35.11 Billion JPY | 10.11% |
| 2013 | 31.89 Billion JPY | -0.16% |
| 2012 | 31.94 Billion JPY | 12.03% |
| 2011 | 28.51 Billion JPY | 4.21% |
| 2010 | 27.36 Billion JPY | 14.09% |
| 2009 | 23.98 Billion JPY | 7.51% |
| 2008 | 22.3 Billion JPY | 6.64% |
| 2007 | 20.91 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 7.63 Billion JPY | -4.58% |
| 2024 Q1 | 7.99 Billion JPY | 4.13% |
| 2023 FY | 30.74 Billion JPY | -2.57% |
| 2023 Q3 | 8.23 Billion JPY | 12.77% |
| 2023 Q2 | 7.3 Billion JPY | -3.14% |
| 2023 Q1 | 7.53 Billion JPY | -0.09% |
| 2023 Q4 | 7.67 Billion JPY | -6.72% |
| 2022 FY | 31.55 Billion JPY | -2.91% |
| 2022 Q1 | 8.42 Billion JPY | 8.3% |
| 2022 Q4 | 7.54 Billion JPY | -3.01% |
| 2022 Q2 | 7.81 Billion JPY | -7.28% |
| 2022 Q3 | 7.77 Billion JPY | -0.44% |
| 2021 Q4 | 7.77 Billion JPY | -15.0% |
| 2021 Q1 | 7.57 Billion JPY | -4.46% |
| 2021 Q2 | 8 Billion JPY | 5.61% |
| 2021 Q3 | 9.15 Billion JPY | 14.4% |
| 2021 FY | 32.5 Billion JPY | 3.06% |
| 2020 Q3 | 8.78 Billion JPY | 14.98% |
| 2020 Q4 | 7.92 Billion JPY | -9.69% |
| 2020 FY | 31.54 Billion JPY | -0.68% |
| 2020 Q1 | 7.19 Billion JPY | -3.94% |
| 2020 Q2 | 7.63 Billion JPY | 6.11% |
| 2019 Q1 | 8.3 Billion JPY | -2.36% |
| 2019 FY | 31.75 Billion JPY | -7.09% |
| 2019 Q2 | 7.79 Billion JPY | -6.15% |
| 2019 Q3 | 8.16 Billion JPY | 4.82% |
| 2019 Q4 | 7.49 Billion JPY | -8.3% |
| 2018 Q2 | 8.09 Billion JPY | -5.31% |
| 2018 Q1 | 8.54 Billion JPY | 5.52% |
| 2018 Q4 | 8.5 Billion JPY | -5.91% |
| 2018 FY | 34.18 Billion JPY | -3.25% |
| 2018 Q3 | 9.03 Billion JPY | 11.7% |
| 2017 Q2 | 8.77 Billion JPY | 0.34% |
| 2017 Q1 | 8.74 Billion JPY | -0.7% |
| 2017 FY | 35.33 Billion JPY | -1.0% |
| 2017 Q4 | 8.09 Billion JPY | -16.68% |
| 2017 Q3 | 9.72 Billion JPY | 10.82% |
| 2016 Q2 | 8.71 Billion JPY | -1.08% |
| 2016 Q4 | 8.8 Billion JPY | -6.05% |
| 2016 FY | 35.68 Billion JPY | 0.24% |
| 2016 Q3 | 9.37 Billion JPY | 7.58% |
| 2016 Q1 | 8.8 Billion JPY | 1.35% |
| 2015 Q4 | 8.68 Billion JPY | -8.41% |
| 2015 FY | 35.6 Billion JPY | 1.38% |
| 2015 Q3 | 9.48 Billion JPY | 7.81% |
| 2015 Q2 | 8.79 Billion JPY | 1.97% |
| 2015 Q1 | 8.62 Billion JPY | 7.96% |
| 2014 Q3 | 9.65 Billion JPY | 11.44% |
| 2014 Q4 | 7.99 Billion JPY | -17.2% |
| 2014 FY | 35.11 Billion JPY | 10.11% |
| 2014 Q1 | 8.81 Billion JPY | 15.98% |
| 2014 Q2 | 8.66 Billion JPY | -1.68% |
| 2013 Q3 | 8.85 Billion JPY | 14.22% |
| 2013 Q4 | 7.59 Billion JPY | -14.19% |
| 2013 FY | 31.89 Billion JPY | -0.16% |
| 2013 Q1 | 7.69 Billion JPY | 9.23% |
| 2013 Q2 | 7.75 Billion JPY | 0.71% |
| 2012 Q3 | 8.29 Billion JPY | 0.22% |
| 2012 Q1 | 8.33 Billion JPY | 27.59% |
| 2012 Q4 | 7.04 Billion JPY | -15.02% |
| 2012 FY | 31.94 Billion JPY | 12.03% |
| 2012 Q2 | 8.27 Billion JPY | -0.78% |
| 2011 Q2 | 7.05 Billion JPY | 2.74% |
| 2011 Q3 | 8.06 Billion JPY | 14.38% |
| 2011 Q4 | 6.53 Billion JPY | -18.98% |
| 2011 FY | 28.51 Billion JPY | 4.21% |
| 2011 Q1 | 6.86 Billion JPY | 1.73% |
| 2010 FY | 27.36 Billion JPY | 14.09% |
| 2010 Q3 | 7.35 Billion JPY | 8.44% |
| 2010 Q1 | 6.48 Billion JPY | 4.56% |
| 2010 Q4 | 6.74 Billion JPY | -8.22% |
| 2010 Q2 | 6.77 Billion JPY | 4.49% |
| 2009 Q2 | 5.82 Billion JPY | 1.27% |
| 2009 Q1 | 5.75 Billion JPY | 3.66% |
| 2009 FY | 23.98 Billion JPY | 7.51% |
| 2009 Q4 | 6.2 Billion JPY | 0.13% |
| 2009 Q3 | 6.19 Billion JPY | 6.33% |
| 2008 Q2 | 5.56 Billion JPY | 0.0% |
| 2008 Q4 | 5.55 Billion JPY | -4.38% |
| 2008 FY | 22.3 Billion JPY | 6.64% |
| 2008 Q3 | 5.8 Billion JPY | 4.29% |
| 2007 FY | 20.91 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | 50.524% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 99.279% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 90.225% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | 92.933% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -297.342% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | 79.26% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | 57.321% |
| Eisai Co., Ltd. | 741.75 Billion JPY | 95.855% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -147.848% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | 78.302% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | 70.114% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | 44.504% |
| Tsumura & Co. | 150.84 Billion JPY | 79.616% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | 59.317% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | 43.724% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 86.51% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | 24.801% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | 59.395% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | 74.276% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -510.079% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | 34.432% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -450.082% |
| MedRx Co., Ltd | 26 Million JPY | -118161.538% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -179.788% |
| Solasia Pharma K.K. | 617 Million JPY | -4883.468% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | 51.072% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | 82.615% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -50214.177% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 97.918% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -38.917% |